These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27987679)

  • 1. Ursolic acid liposomes with chitosan modification: Promising antitumor drug delivery and efficacy.
    Wang M; Zhao T; Liu Y; Wang Q; Xing S; Li L; Wang L; Liu L; Gao D
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():1231-1240. PubMed ID: 27987679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
    Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
    Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
    Jin H; Pi J; Yang F; Jiang J; Wang X; Bai H; Shao M; Huang L; Zhu H; Yang P; Li L; Li T; Cai J; Chen ZW
    Sci Rep; 2016 Jul; 6():30782. PubMed ID: 27469490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Antitumor Activity of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid in Animal Models of Breast Tumor and Gliosarcoma.
    Rocha TG; Lopes SC; Cassali GD; Ferreira Ê; Veloso ES; Leite EA; Braga FC; Ferreira LA; Balvay D; Garofalakis A; Oliveira MC; Tavitian B
    Integr Cancer Ther; 2016 Dec; 15(4):512-524. PubMed ID: 27130721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
    Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
    Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.
    Zhao R; Zheng G; Fan L; Shen Z; Jiang K; Guo Y; Shao JW
    Acta Biomater; 2018 Apr; 70():197-210. PubMed ID: 29408311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
    Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
    J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
    Das S; Ghosh S; De AK; Bera T
    Int J Biol Macromol; 2017 Sep; 102():996-1008. PubMed ID: 28465178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid
    Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G
    Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes.
    Zhao T; Liu Y; Gao Z; Gao D; Li N; Bian Y; Dai K; Liu Z
    Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():196-203. PubMed ID: 26042707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
    Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan modified poly (lactic acid) nanoparticles increased the ursolic acid oral bioavailability.
    Antonio E; Dos Reis Antunes Junior O; Marcano RGDJV; Diedrich C; da Silva Santos J; Machado CS; Khalil NM; Mainardes RM
    Int J Biol Macromol; 2021 Mar; 172():133-142. PubMed ID: 33450338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity evaluation of novel ursolic acid derivatives.
    Meng YQ; Zhang LF; Liu DY; Liu LW; Zhang Y; Zhao MJ
    J Asian Nat Prod Res; 2016; 18(3):280-8. PubMed ID: 26524942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Near Infrared Photothermal Therapy and Chemotherapy Using Gold Nanoshells Coated Liposomes to Enhance Antitumor Effect.
    Luo L; Bian Y; Liu Y; Zhang X; Wang M; Xing S; Li L; Gao D
    Small; 2016 Aug; 12(30):4103-12. PubMed ID: 27294601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, physicochemical characterization, and cell viability evaluation of long-circulating and pH-sensitive liposomes containing ursolic acid.
    Caldeira de Araújo Lopes S; Vinícius Melo Novais M; Salviano Teixeira C; Honorato-Sampaio K; Tadeu Pereira M; Ferreira LA; Braga FC; Cristina Oliveira M
    Biomed Res Int; 2013; 2013():467147. PubMed ID: 23984367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
    Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
    Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes.
    Liu Y; Gao D; Zhang X; Liu Z; Dai K; Ji B; Wang Q; Luo L
    Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():124-132. PubMed ID: 27127036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma.
    Dong H; Yang X; Xie J; Xiang L; Li Y; Ou M; Chi T; Liu Z; Yu S; Gao Y; Chen J; Shao J; Jia L
    Biochem Pharmacol; 2015 Jan; 93(2):151-62. PubMed ID: 25522955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.